Xcelience has opened its new 71,000 square foot headquarters located at 4910 Savarese Circle in Tampa, FL. The building houses preformulation and formulation development labs and suites, as well as analytical and stability services.

The new facility features a state-of-the art formulation lab, as well as the executive headquarters. In addition, build out plans for a new analytical lab at the site are also under development.

“This year marks a rapid expansion in our service offerings,” said Derek Hennecke, president and chief executive officer, Xcelience. “In July we integrated with Powdersize because so many of our clients needed industry-leading micronization services. Now, with this new facility, we will be able to increase capacity throughout the organization. More capacity means we can be more flexible in dealing with changing client needs and timelines.”

The company’s previous headquarters on West Laurel Street in Tampa is transitioning to provide clinical trial and small-scale commercial manufacturing.